Literature DB >> 25523257

Hidradenitis suppurativa outcome measures and treatment goals.

J R Ingram1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25523257     DOI： 10.1111/bjd.13396

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  1 in total

Review 1.  Adalimumab for Treating Moderate-to-Severe Hidradenitis Suppurativa: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Authors:  Paul Tappenden; Christopher Carroll; John W Stevens; Andrew Rawdin; Sabine Grimm; Mark Clowes; Eva Kaltenthaler; John R Ingram; Fiona Collier; Mohammad Ghazavi
Journal:  Pharmacoeconomics       Date:  2017-08       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.